# The Effect of Echinacea (Immulant ®) in the Treatment of CRYPTOSPORIDIOSIS in Immunocompromised Children

> **NCT07388615** · PHASE2 · RECRUITING · sponsor: **Al-Azhar University** · enrollment: 60 (estimated)

## Conditions studied

- Cryptosporidium Infection

## Interventions

- **DRUG:** Echinacea Extract

## Key facts

- **NCT ID:** NCT07388615
- **Lead sponsor:** Al-Azhar University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-18
- **Primary completion:** 2026-06
- **Final completion:** 2026-08
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07388615

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07388615, "The Effect of Echinacea (Immulant ®) in the Treatment of CRYPTOSPORIDIOSIS in Immunocompromised Children". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07388615. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*